GlobeNewswire Inc | Nov 19, 2021 04:01PM EST

November 19, 2021

CAMBRIDGE, Mass., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that Dr. Robert Ang, Vors President and Chief Executive Officer, will be participating at the Piper Sandler 33rd Virtual Annual Healthcare Conference.

Piper Sandler 33rd Virtual Annual Healthcare ConferenceDate: Tuesday, November 30 through Thursday, December 2, 2021

Vors pre-recorded presentation will be available on-demand from Piper Sandler beginning on Monday, November 22nd at 10:00 am ET and can also be accessed via the Investors section of the Company's website atwww.vorbio.com.

About Vor BiopharmaVor Biopharma is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit:www.vorbio.com.

Contacts:

Investors:Chris BrinzeyICR Westwicke+1 339-970-2843chris.brinzey@westwicke.com

Media:Vice President, Corporate Communications, VorSarah Spencer+1 857-242-6076sspencer@vorbio.com